Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GABA in children with newly diagnosed type 1 diabetes mellitus
NCT01561508Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2012
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 2 trial of gamma-aminobutyric acid in type 1 diabetes mellitus (T1D), sponsored by University of Alabama at Birmingham. Planned start Jun 2012; status: withdrawn.
02
Drugs
gamma-aminobutyric acid
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01561508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561508.